ABOUT US

Chairman

Hans T. Schambye, MD, PhD

Board member

Hans Schambye is an independent biotech consultant and board member. He currently served as Chairman of the Board for Rose Pharma and Nanoference. Previously, Dr. Schambye served as the Chief Executive Officer of ReceptIcon from 2006 to 2009 and as the CEO of Gastrotech Pharma A/S from 2005 to 2006. Before joining Gastrotech, Dr. Schambye was Director of Biology and Pharmacology and Head of Portfolio Management at Maxygen, a US biotech company. In 1999, Dr. Schambye co-founded ProFound Pharma A/S, a Danish biotech company, which was acquired by Maxygen in 2000. Prior to this Dr. Schambye had a successful research career at Stanford University and Copenhagen University within the field of receptor biology. Dr. Schambye holds an MD from Odense University and a PhD in Medical Sciences from Copenhagen University.

Florian Schönharting, MSc

Board member

Florian Schönharting is co-founder and partner of Nordic Biotech. Read more.

Torsten Goesch, MD, PhD, MBA

Board member

Dr. Goesch is a director of BioScience Managers Limited (BML) which he joined in July 2002. Read more.

Wyle Solomon , MSc, MBA

Board member

Wyle Solomon is Vice President at Nordic Biotech.  He came to Nordic Biotech in June 2007. Read more.